Nimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer

BACKGROUND: Nimotuzumab is an anti-EGFR monoclonal antibody which has been widely used in cancer treatment. However, the safety and efficacy of nimotuzumab combined with chemotherapy in locally advanced or metastatic esophageal cancer patients remain unclear. MATERIAL/METHODS: To address this open q...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xinghua, Lu, Nannan, Pan, Yueyin, Xu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286920/
https://www.ncbi.nlm.nih.gov/pubmed/28115730
http://dx.doi.org/10.12659/MSM.902645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286920/
https://www.ncbi.nlm.nih.gov/pubmed/28115730
http://dx.doi.org/10.12659/MSM.902645

Ejemplares similares